Literature DB >> 6865764

Gonadal dysfunction in the spontaneously diabetic BB rat.

F T Murray, D F Cameron, J M Orth.   

Abstract

Diabetes which occurs spontaneously in the BB Wistar rat is associated with reduced fertility, predominantly in breeding males. In the first month of diabetes, there is a significant (p less than 0.05) reduction in serum testosterone associated with a transient decrease of serum LH and the accumulation of lipid in Leydig cells. Between one and three months of diabetes, there is an increase in both serum testosterone and LH and a further deposition of lipid droplets in Leydig cells. From three to six months of diabetes, there is a reduction of serum testosterone similar to age-matched controls, but high serum LH levels persist. Similar levels of LH and testosterone are noted after six months of diabetes, and all BB rats show marked changes in seminiferous tubules. These morphological changes in tubules consist of increased tubular wall thickness, severe germ-cell depletion, and Sertoli-cell vacuolization. Similar morphological changes of testes associated with generalized atrophy are noted in all control rats after 16 months of age. Decreased fertility in the BB rat appears to be associated with a primary disorder of Leydig cells, which precedes changes in seminiferous tubules consistent with accelerated aging. Preliminary data in impotent diabetic men suggest that the BB rat may be a valuable model for investigating human diabetic impotence and infertility.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6865764     DOI: 10.1016/s0026-0495(83)80028-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Enalapril reduces germ cell toxicity in streptozotocin-induced diabetic rat: investigation on possible mechanisms.

Authors:  S Kushwaha; G B Jena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-10       Impact factor: 3.000

2.  p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.

Authors:  Feng Bai; Ho Lam Chan; Matthew D Smith; Hiroaki Kiyokawa; Xin-Hai Pei
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

3.  Testicular alterations in the nonobese diabetic mouse.

Authors:  Guy W Tarleton; Bernard Gondos; Brent Formby
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

4.  [The influence of diabetes mellitus on male reproductive function: a poorly investigated aspect of male infertility].

Authors:  C Mallidis; I Agbaje; N McClure; S Kliesch
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

Review 5.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

6.  Decreased spermatogenesis, fertility, and altered Slc2A expression in Akt1-/- and Akt2-/- testes and sperm.

Authors:  Sung Tae Kim; Kenan Omurtag; Kelle H Moley
Journal:  Reprod Sci       Date:  2012-01       Impact factor: 3.060

7.  Endocrine profile and testicular histomorphometry in adult rat offspring of diabetic mothers.

Authors:  Gholamali Jelodar; Zabiholah Khaksar; Mohammad Pourahmadi
Journal:  J Physiol Sci       Date:  2009-06-18       Impact factor: 2.781

8.  Protective Effect of Rutin and Naringin on Sperm Quality in Streptozotocin (STZ) Induced Type 1 Diabetic Rats.

Authors:  Raju Butchi Akondi; Phani Kumar; Akula Annapurna; Manasa Pujari
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

Review 9.  Diabetes, insulin-mediated glucose metabolism and Sertoli/blood-testis barrier function.

Authors:  Marco G Alves; Ana D Martins; José E Cavaco; Sílvia Socorro; Pedro F Oliveira
Journal:  Tissue Barriers       Date:  2013-04-01

10.  Animal Models of Diabetes-Related Male Hypogonadism.

Authors:  Anastasia Dimakopoulou; Channa N Jayasena; Utsav K Radia; Metab Algefari; Suks Minhas; Nick Oliver; Waljit S Dhillo
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.